Ricardo RJM, Mustelier SLR, Pérez AJ, Ferrer AM, Romero GLI

Language: Spanish
References: 15
Page: 4073-4080
PDF size: 183.69 Kb.

ABSTRACT

An applied explanatory cohort study was conducted in 132 patients operated for breast cancer, with clinical follow-up at the Mastology Department of "Saturnino Lora Torres" Provincial Teaching Clinical Surgical Hospital of Santiago de Cuba, from January 2002 to the same month of 2012, to assess their survival and identify some predictive factors associated with mortality from this condition. The predominant tissular alteration was infiltrating ductal carcinoma in the case material, with 60.0% of survival in females, while the worst prognosis was mixed carcinoma without survival at the end of follow-up, and that of the best survival was lobular carcinoma. Patients with tumors in stages 0, I and IIA showed improved survival (100.0; 92.5 and 77.0%, respectively) and among women who developed distant metastases were predominance of liver and bone spread and better survival in those with locoregional metastatic lesions.

REFERENCES

1. Rohan TE, Bain CJ. Diet in the etiology of breast cancer. Epidemiol Rev. 1987; 9(1): 120-45.

2. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER cancer statistics review, 1975-2005. Bethesda, MD: U.S. National Institutes of Health, National Cancer Institute; 2008.

3. Izquierdo A, Gispert R, Saladie F, Espinás JA. Análisis de la incidencia, la supervivencia y la mortalidad según las principales localizaciones tumorales, 1985- 2019: cáncer de mama. Med Clin (Barc). 2008; 131(Supl 1): 50-2.

4. Brekelmans CT, Tilanus-Linthorst MM, Seynaeve C, vd Ouweland A, Menke-Pluymers MB, Bartels CC. Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA½ families as compared to sporadic breast cancer cases. Eur J Cancer. 2007; 43(5): 867-76.

5. Vera Álvarez JJ. Factores pronósticos de cáncer de mama. Boletín Oncológico. 2000 [citado 30 Nov 2011]; 1(13). Disponible en: http://www.boloncol.com/boletin- 13/factores-pronostico-del-cancer-de-mama.html

6. Kaplan MP, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53(282): 457-81.

7. Ocón Hernández O, Fernández Cabrera MF, Pérez Vicente S, Dávila Arias C, Expósito Hernández J, Olea Serrano N. Supervivencia en cáncer de mama tras 10 años de seguimiento en las provincias de Granada y Almería. Rev Esp Salud Pública. 2010; 85(6): 705-15.

8. Cuba. Ministerio de Salud Pública. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2010. La Habana: MINSAP [citado 30 Nov 2011]; 2011. Disponible en: http://files.sld.cu/dne/files/2011/04/ anuario-2010-e-sin-graficos1.pdf

9. Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, et al. Breast Cancer. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2009; 7(2): 122-92.

10. Guerin S, Doyon F, Hill C. The frequency of cancer in France in 2006, mortality trends since 1950, incidence trends since 1980 and analysis of the discrepancies between these trends. Bull Cancer. 2009; 96(1): 51-7.

11. Yildirim E, Berberoglu U. Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients. World J Surg. 2007; 31(2): 276-89.

12. Flores Luna L, Salazar Martínez E, Duarte Torres RM, Torres Mejía G, Alonso Ruiz P, Lazcano Ponce E. Factores pronósticos relacionados con la supervivencia del cáncer de mama. Salud Pública Mex. 2008; 50(2): 119-25.

13. García Rosado MV. Epidemiología descriptiva del cáncer de mama en la comunidad autónoma de Madrid. Análisis de supervivencia [tesis doctoral]. Madrid: Universidad Complutense de Madrid [citado 30 Nov 2011]; 2008. Disponible en: http://eprints.ucm.es/8584/1/T30712.pdf

14. Sarp S, Fioretta G, Verkooijen HM, Vlastos G, Rapiti E, Schubert H, et al. Tumor location of the lower inner quadrant is associated with an impaired survival for women with early-stage breast cancer. Ann Surg Oncol. 2007; 14(3): 1031-9.

15. Jemal A, Center MM, De Santis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010; 19(8): 1893-7.